Page last updated: 2024-09-04

glucagon and nateglinide

glucagon has been researched along with nateglinide in 10 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(nateglinide)
Trials
(nateglinide)
Recent Studies (post-2010) (nateglinide)
26,0391,4983,054441112120

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (50.00)18.2507
2000's4 (40.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dan, K; Fujita, T; Hirose, H; Ito, K; Kanda, N; Kato, R; Maruyama, H; Saruta, T; Seto, Y1
Dan, K; Hirose, H; Ito, K; Kato, R; Kido, K; Koyama, K; Maruyama, H; Saruta, T; Seto, Y1
Akiyoshi, M; Fujitani, S; Ikenoue, T; Maki, T; Yada, T1
Fuhlendorff, J; Ladrière, L; Leclercq-Meyer, V; Malaisse, WJ1
Bokvist, K; Buschard, K; Gromada, J; Holst, JJ; Hoy, M; Thomsen, MK1
de Souza, CJ; Dunning, BE; Lozito, R; Russo, P1
Deacon, R; Dunning, BE; Foley, JE; Gutierrez, C; Paladini, S; Valentin, MA1
Bauer, S; Brockmöller, J; Kirchheiner, J; Meineke, I; Meisel, C; Müller, G; Rohde, W; Roots, I1
Groop, LC; Honkanen, EH; Isomaa, B; Sarelin, L; Tuomi, T1
Breitschaft, A; Darstein, C; Golor, G; Hermosillo Reséndiz, K; Hu, K1

Trials

3 trial(s) available for glucagon and nateglinide

ArticleYear
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.
    Clinical pharmacokinetics, 2004, Volume: 43, Issue:4

    Topics: Adult; Alleles; Aryl Hydrocarbon Hydroxylases; Blood Glucose; Cyclohexanes; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Female; Genotype; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Clearance Rate; Nateglinide; Phenylalanine; Polymorphism, Genetic; Prospective Studies

2004
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
    Diabetes care, 2006, Volume: 29, Issue:2

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise Test; Female; Glucagon; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period

2006
Management of hyperglycemia associated with pasireotide (SOM230): healthy volunteer study.
    Diabetes research and clinical practice, 2014, Volume: 103, Issue:3

    Topics: Adamantane; Adolescent; Adult; Blood Glucose; Cyclohexanes; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Healthy Volunteers; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Liraglutide; Male; Maximum Tolerated Dose; Metformin; Middle Aged; Nateglinide; Nitriles; Phenylalanine; Prognosis; Pyrrolidines; Somatostatin; Vildagliptin; Young Adult

2014

Other Studies

7 other study(ies) available for glucagon and nateglinide

ArticleYear
Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
    Pharmacology, 1995, Volume: 50, Issue:3

    Topics: Analysis of Variance; Animals; Cyclohexanes; Diazoxide; Drug Interactions; Glucagon; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Perfusion; Phenylalanine; Rats; Rats, Wistar

1995
Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas.
    Pharmacology, 1994, Volume: 48, Issue:4

    Topics: Animals; Cyclohexanes; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Nateglinide; Pancreas; Perfusion; Phenylalanine; Radioimmunoassay; Rats

1994
Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.
    Metabolism: clinical and experimental, 1996, Volume: 45, Issue:2

    Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Cyclohexanes; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Nateglinide; Pancreas; Perfusion; Phenylalanine; Potassium Channels; Rats; Rats, Wistar; Somatostatin; Time Factors

1996
Stimulation of insulin and somatostatin release by two meglitinide analogs.
    Endocrine, 1997, Volume: 7, Issue:3

    Topics: Animals; Benzamides; Blood Glucose; Carbamates; Cyclohexanes; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Perfusion; Phenylalanine; Piperidines; Rats; Rats, Wistar; Somatostatin

1997
Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.
    European journal of pharmacology, 1999, Dec-10, Volume: 386, Issue:1

    Topics: Animals; ATP-Binding Cassette Transporters; Calcium; Carbamates; Cyclohexanes; Eating; Electrophysiology; Exocytosis; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Islets of Langerhans; KATP Channels; Kinetics; Male; Nateglinide; Patch-Clamp Techniques; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred Lew; Stimulation, Chemical

1999
Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.
    Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:2

    Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Food; Glipizide; Glucagon; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley

2001
Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia.
    Diabetologia, 2003, Volume: 46 Suppl 1

    Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Fatty Acids, Nonesterified; Food; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Macaca fascicularis; Male; Nateglinide; Phenylalanine; Piperidines

2003